Comparison of longer-term outcomes after kidney transplantation between hispanic and non-hispanic whites in the United States

American Journal of Transplantation

Volumn 15, Issue 2, 2015, Pages 499-507

  Arce, C M ^a,b   Lenihan, C R ^b   Montez Rath, M E ^b   Winkelmayer, W C ^b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

disparities; epidemiology; health services and outcomes research; kidney transplantation nephrology

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; ASSOCIATION; CAUCASIAN; COMORBIDITY; DEATH; DIABETES MELLITUS; ETHNICITY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEART FAILURE; HEMODIALYSIS; HISPANIC; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; UNITED STATES; ADOLESCENT; AGE; AGED; COMPARATIVE STUDY; ETHNOLOGY; FOLLOW UP; GRAFT REJECTION; INCIDENCE; LONGITUDINAL STUDY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY; RETROSPECTIVE STUDY; SURVIVAL RATE; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HISPANIC AMERICANS; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 84921599550     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13043     Document Type: Article

References (43)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242.
3. Butkus DE, Meydrech EF, Raju SS., Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992; 327: 840-845.
4. Chertow GM, Milford EL., Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching. Adv Ren Replace Ther 1997; 4: 40-45.
5. Isaacs RB, Nock SL, Spencer CE, et al. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999; 34: 706-712.
6. Katznelson S, Gjertson DW, Cecka JM., The effect of race and ethnicity on kidney allograft outcome. Clin Transpl 1995; 379-394.
7. Wolfe RA, Ashby VB, Milford EL, et al. Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis 2000; 36: 1025-1033.
8. Leffell MS, Steinberg AG, Bias WB, Machan CH, Zachary AA., The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry. Transplantation 1994; 58: 1119-1130.
9. Neylan JF., Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1997; 64: 1277-1282.
10. Neylan JF., Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. Transplantation 1998; 65: 515-523.
11. Gaston RS, Hudson SL, Deierhoi MH, et al. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation 1992; 53: 103-109.
12. Lindholm A, Welsh M, Alton C, Kahan BD., Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability. Clin Pharmacol Ther 1992; 52: 359-371.
13. Schold JD, Kaplan B, Chumbler NR, et al. Access to quality: Evaluation of the allocation of deceased donor kidneys for transplantation. J Am Soc Nephrol 2005; 16: 3121-3127.
14. Meier-Kriesche HU, Kaplan B., Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002; 74: 1377-1381.
15. Mange KC, Joffe MM, Feldman HI., Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001; 344: 726-731.
16. Gaston RS, Hudson SL, Ward M, Jones P, Macon R., Late renal allograft loss: Noncompliance masquerading as chronic rejection. Transplant Proc 1999; 31: 21S-23S.
17. Press R, Carrasquillo O, Nickolas T, Radhakrishnan J, Shea S, Barr RG., Race/ethnicity, poverty status, and renal transplant outcomes. Transplantation 2005; 80: 917-924.
18. Keith D, Ashby VB, Port FK, Leichtman AB., Insurance type and minority status associated with large disparities in prelisting dialysis among candidates for kidney transplantation. Clin J Am Soc Nephrol 2008; 3: 463-470.
19. Patzer RE, Amaral S, Wasse H, Volkova N, Kleinbaum D, McClellan WM., Neighborhood poverty and racial disparities in kidney transplant waitlisting. J Am Soc Nephrol 2009; 20: 1333-1340.
20. Reeves-Daniel AM, DePalma JA, Bleyer AJ, et al. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11: 1025-1030.
21. Humes KR, Jones NA, Ramirez RR, United States Bureau of the Census. Overview of race and Hispanic origin: 2010. Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau, 2011.
22. Peralta CA, Shlipak MG, Fan D, et al. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2892-2899.
23. US Renal Data System, USRDS. 2012; Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes, Digestive, Kidney Disease, 2012.
24. Bryson CL, Ross HJ, Boyko EJ, Young BA., Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: Associations with diabetes and level of CKD. Am J Kidney Dis 2006; 48: 720-726.
25. Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-459.
26. Fischer MJ, Go AS, Lora CM, et al. CKD in Hispanics: Baseline characteristics from the CRIC (chronic renal insufficiency cohort) and Hispanic-CRIC studies. Am J Kidney Dis 2011; 58: 214-227.
27. Sequist TD, Narva AS, Stiles SK, Karp SK, Cass A, Ayanian JZ., Access to renal transplantation among American Indians and Hispanics. Am J Kidney Dis 2004; 44: 344-352.
28. Kasiske BL, London W, Ellison MD., Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol 1998; 9: 2142-2147.
29. Hall YN, Choi AI, Xu P, O'Hare AM, Chertow GM., Racial ethnic differences in rates and determinants of deceased donor kidney transplantation. J Am Soc Nephrol 2011; 22: 743-751.
30. Montez-Rath ME, Winkelmayer WC, Desai M., Addressing missing data in clinical studies of kidney diseases. Clin J Am Soc Nephrol 2014; 9: 1328-1335.
31. von Hippel PT., How to impute interactions, squares and other transformed variables. Sociol Methodol 2009; 39: 265-291.
32. Little RJA, Rubin DB., Statistical analysis with missing data. New York: Wiley; 1987.
33. Salvatierra O, Jr., Demographic and transplantation trends among minority groups. Transplant Proc 1989; 21: 3916-3917.
34. Milgrom M, Gharagozloo H, Gomez C, et al. Results of renal transplantation in Miami analyzed by race. Transplant Proc 1989; 21: 3934-3936.
35. Gjertson DW., A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update. Clin Transpl 1996; 343-360.
36. Gjertson DW., Determinants of long-term survival of adult kidney transplants: A 1999 UNOS update. Clin Transpl 1999; 341-352.
37. Fan PY, Ashby VB, Fuller DS, et al. Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant 2010; 10: 1090-1107.
38. Siegal B, Greenstein S., Compliance and noncompliance in kidney transplant patients: Cues for transplant coordinators. J Transpl Coord 1999; 9: 104-108.
39. Kiley DJ, Lam CS, Pollak R., A study of treatment compliance following kidney transplantation. Transplantation 1993; 55: 51-56.
40. Frankenfield DL, Rocco MV, Roman SH, McClellan WM., Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project. J Am Soc Nephrol 2003; 14: 180-186.
41. Woodward RS, Schnitzler MA, Lowell JA, Spitznagel EL, Brennan DC., Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants. Am J Transplant 2001; 1: 69-73.
42. Kim JP, Desai M, Chertow GM, Winkelmayer WC., Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol 2012; 23: 1078-1085.
43. Kalil RS, Heim-Duthoy KL, Kasiske BL., Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 1992; 20: 63-69.